In addition, mutations of KCNQ2 are known to cause not only benign epilepsy, but also malignant phenotypes, e.g., EOEE and Ohtahara syndrome, for which treatments based on an understanding of the underlying pathomechanisms are urgently required [8–11]. Here, KCNQ2 is linked to early-infantile DEE.